Skip to content

Precigen PGEN Shares (Diluted)

Shares (Diluted) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
107.7M-3.1%
Gilead Sciences logo
Gilead SciencesGILD
1.3B-0.4%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
81.3M+33.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
58.8M+2.3%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
69.7M+19.7%
Arrowhead Research logo
Arrowhead ResearchARWR
142.4M+5.9%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's shares (diluted)?
Precigen (PGEN) reported shares (diluted) of 354.3M in Q1 2026.
How has Precigen's shares (diluted) changed year-over-year?
Precigen's shares (diluted) increased by 20.6% year-over-year, from 293.9M to 354.3M.
What is the long-term trend for Precigen's shares (diluted)?
Over 4 years (2021 to 2025), Precigen's shares (diluted) has grown at a 11.3% compound annual growth rate (CAGR), from 789.5M to 1.2B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.